ClinicalTrials.govpublic full text
Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19
covid-19, pharmacokinetics, safety, pharmacodynamics, sotrovimab, pediatric, intravenous, intramuscular, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902093
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.